LeeA., LauT.N., YeongK.Y.Indwelling catheters for the management of malignant ascites.Support Care Cancer2000; 8(6): 493–499.
9.
HydeG.L., DillonM., BivinsB.A.Peritoneal venous shunting for ascites: a 15-year perspective.Am Surg1982; 48(3): 123–127.
10.
ValleM., Van der SpeetenK., GarofaloA.Laparoscopic hyper-thermic intraperitoneal perioperative chemotherapy (HIPEC) in the management of refractory malignant ascites: a multi-institutional retrospective analysis in 52 patients.J Surg Oncol2009; 100(4): 331–334.
11.
PatritiA., CavazzoniE., GraziosiL.Successful palliation of malignant ascites from peritoneal mesothelioma by laparoscopic intraperitoneal hyperthermic chemotherapy.Surg Laparosc Endosc Percutan Tech2008; 18(4): 426–428.
12.
FacchianoE., ScaringiS., KianmaneshR.Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer.Eur J Surg Oncol2008; 34(2): 154–158.
13.
GarofaloA., ValleM., GarciaJ.Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites.Eur J Surg Oncol2006; 32(6): 682–685.
14.
FlemingL.Phase 1 study of intraperitoneal hypertehermic administration of mitomycin C administered by the Thermo-Chem-HT device for advanced GI and ovarian cancer.Wake Forest University School of Medicine. Report submitted to ViaCirq Inc., Canonsburg (PA); 2001.